908 Devices (MASS) Cash & Equivalents (2020 - 2026)

908 Devices (MASS) has reported Cash & Equivalents for 7 consecutive years, with $63.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 2.05% year-over-year to $63.0 million in Q2 2026; TTM through Jun 2026 was $63.0 million, a 2.05% increase from a year earlier, with the FY2025 full-year figure at $70.5 million, up 60.15% from the prior year.
• Cash & Equivalents was $63.0 million for Q2 2026 at 908 Devices, down from $67.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $223.1 million in Q1 2022 and troughed at $44.0 million in Q4 2024.
• A 5-year average of $110.9 million and a median of $91.9 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents slumped 64.8% in 2024 and soared 60.15% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $188.4 million in 2022, then sank by 35.76% to $121.0 million in 2023, then tumbled by 63.62% to $44.0 million in 2024, then soared by 60.15% to $70.5 million in 2025, then slipped by 10.63% to $63.0 million in 2026.
• The last three Cash & Equivalents figures came in at $63.0 million (Q2 2026), $67.6 million (Q1 2026), and $70.5 million (Q4 2025), per Business Quant data.